What is Taro Pharmaceutical Industries Price-to-Free-Cash-Flow?
As of today (2024-04-25), Taro Pharmaceutical Industries's share price is $42.20.
Taro Pharmaceutical Industries's Free Cash Flow per Share for the trailing twelve months (TTM) ended in Dec. 2023 was $2.29. Hence, Taro Pharmaceutical Industries's Price-to-Free-Cash-Flow Ratio for today is 18.44.
The historical rank and industry rank for Taro Pharmaceutical Industries's Price-to-Free-Cash-Flow or its related term are showing as below:
TARO'
s Price-to-Free-Cash-Flow Range Over the Past 10 Years
Min: 9.08 Med: 14.18 Max: 263.64
Current: 18.44
During the past 13 years, Taro Pharmaceutical Industries's highest Price-to-Free-Cash-Flow Ratio was 263.64. The lowest was 9.08. And the median was 14.18.
TARO's Price-to-Free-Cash-Flow is ranked better than 57.49% of 494
companies
in the Drug Manufacturers industry
Industry Median: 21.73
vs TARO: 18.44
Taro Pharmaceutical Industries's Free Cash Flow per Share for the
three
months ended in Dec. 2023 was $-0.10.
Its Free Cash Flow per Share for the trailing twelve months (TTM) ended in was $2.29.
During the past 3 years, the average Free Cash Flow per Share Growth Rate was -63.10% per year.
During the past 13 years, Taro Pharmaceutical Industries's highest 3-Year average Free Cash Flow per Share Growth Rate was 73.80% per year. The lowest was -131.20% per year. And the median was 4.50% per year.
Taro Pharmaceutical Industries Price-to-Free-Cash-Flow Historical Data
The historical data trend for Taro Pharmaceutical Industries's Price-to-Free-Cash-Flow can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Taro Pharmaceutical Industries's Price-to-Free-Cash-Flow
For the Drug Manufacturers - Specialty & Generic subindustry, Taro Pharmaceutical Industries's Price-to-Free-Cash-Flow, along with its competitors' market caps and Price-to-Free-Cash-Flow data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Taro Pharmaceutical Industries's Price-to-Free-Cash-Flow Distribution in the Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Taro Pharmaceutical Industries's Price-to-Free-Cash-Flow distribution charts can be found below:
* The bar in red indicates where Taro Pharmaceutical Industries's Price-to-Free-Cash-Flow falls into.
Taro Pharmaceutical Industries's Share Price of today is $42.20.
Taro Pharmaceutical Industries's Free Cash Flow per Share for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $2.29.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
Free Cash Flow is considered more important than earnings by value investors. The reason is because, in principle, only the net cash that can be taken from the business belongs to shareholders. This Free Cash Flow can be used to grow the business, reduce debt or return to shareholders in dividends or share buybacks.
In a DCF Calculation Free Cash Flow is used to determine the intrinsic value of companies.
Be Aware
In real business, Free Cash Flow can be affected by the change in accounts receivable, accounts payable, management's decision on expansion, etc. Therefore, investors should look at the Free Cash Flow over the longer term. Long-term average of Free Cash Flow is a more reliable indicator for real free cash flow.
Taro Pharmaceutical Industries Price-to-Free-Cash-Flow Related Terms
Thank you for viewing the detailed overview of Taro Pharmaceutical Industries's Price-to-Free-Cash-Flow provided by GuruFocus.com. Please click on the following links to see related term pages.
Taro Pharmaceutical Industries (Taro Pharmaceutical Industries) Business Description
Taro Pharmaceutical Industries Ltd produces, researches, develops, and markets pharmaceutical products. Its primary focus includes semi-solid formulations, such as creams and ointments, and other dosage forms such as liquids, capsules, and tablets. The company is engaged in the dermatological and topical, cardiovascular, neuropsychiatric, and anti-inflammatory therapeutic categories. Geographically, it derives a majority of its revenue from the United States and also has a presence in Canada, Israel, and Other Countries.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
TARO has been successfully added to your 